7,369 Shares in Cigna Group $CI Acquired by Gator Capital Management LLC

Gator Capital Management LLC purchased a new position in Cigna Group (NYSE:CI) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 7,369 shares of the health services provider’s stock, valued at approximately $2,028,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after buying an additional 4,066 shares during the period. Compass Wealth Management LLC acquired a new position in Cigna Group in the 3rd quarter worth approximately $4,718,000. Varma Mutual Pension Insurance Co increased its holdings in Cigna Group by 9.6% in the 3rd quarter. Varma Mutual Pension Insurance Co now owns 40,942 shares of the health services provider’s stock worth $11,802,000 after buying an additional 3,600 shares during the period. Alberta Investment Management Corp acquired a new position in Cigna Group in the 3rd quarter worth approximately $3,171,000. Finally, Distillate Capital Partners LLC grew its stake in shares of Cigna Group by 19.1% during the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock worth $31,338,000 after purchasing an additional 17,442 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $297.77 on Friday. The company’s fifty day moving average price is $282.53 and its 200 day moving average price is $278.01. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The stock has a market capitalization of $78.77 billion, a P/E ratio of 12.62, a P/E/G ratio of 1.14 and a beta of 0.28. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the company earned $6.74 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CI shares. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research note on Friday, May 1st. Morgan Stanley raised their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, June 6th. Wells Fargo & Company raised their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Finally, Sanford C. Bernstein raised their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.